Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
58.25
-1.08 (-1.82%)
At close: Feb 19, 2026, 4:00 PM EST
57.53
-0.72 (-1.24%)
After-hours: Feb 19, 2026, 6:39 PM EST
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$392,122
Profits / Employee
$26,148
Market Cap
9.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,100 | 0 | - |
| Jun 30, 2024 | 3,100 | 50 | 1.64% |
| Jun 30, 2023 | 3,050 | 50 | 1.67% |
| Jun 30, 2022 | 3,000 | 400 | 15.38% |
| Jun 30, 2021 | 2,600 | 300 | 13.04% |
| Jun 30, 2020 | 2,300 | 50 | 2.22% |
| Jun 30, 2019 | 2,250 | 250 | 12.50% |
| Jun 30, 2018 | 2,000 | 200 | 11.11% |
| Jun 30, 2017 | 1,800 | 240 | 15.38% |
| Jun 30, 2016 | 1,560 | 204 | 15.04% |
| Jun 30, 2015 | 1,356 | 335 | 32.81% |
| Jun 30, 2014 | 1,021 | 167 | 19.56% |
| Jun 30, 2013 | 854 | 7 | 0.83% |
| Jun 30, 2012 | 847 | 13 | 1.56% |
| Jun 30, 2011 | 834 | 97 | 13.16% |
| Jun 30, 2010 | 737 | -9 | -1.21% |
| Jun 30, 2009 | 746 | 27 | 3.76% |
| Jun 30, 2008 | 719 | 38 | 5.58% |
| Jun 30, 2007 | 681 | 44 | 6.91% |
| Jun 30, 2006 | 637 | 28 | 4.60% |
| Jun 30, 2005 | 609 | 12 | 2.01% |
| Jun 30, 2004 | 597 | 11 | 1.88% |
| Jun 30, 2003 | 586 | 16 | 2.81% |
| Jun 30, 2002 | 570 | 9 | 1.60% |
| Jun 30, 2001 | 561 | 64 | 12.88% |
| Jun 30, 2000 | 497 | 26 | 5.52% |
| Jun 30, 1999 | 471 | 60 | 14.60% |
| Jun 30, 1998 | 411 | 46 | 12.60% |
| Jun 30, 1997 | 365 | -7 | -1.88% |
| Jun 30, 1996 | 372 | 28 | 8.14% |
| Jun 30, 1995 | 344 | 67 | 24.19% |
| Jun 30, 1994 | 277 | 71 | 34.47% |
| Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Jazz Pharmaceuticals | 2,800 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 673 |
| Cytokinetics | 498 |
| Vaxcyte | 414 |
| Halozyme Therapeutics | 350 |
| Krystal Biotech | 295 |
TECH News
- 3 days ago - Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories - PRNewsWire
- 8 days ago - Bio-Techne Announces Changes to its Leadership Team - PRNewsWire
- 15 days ago - Bio-Techne Corporation (TECH) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Biotech firm Bio-Techne beats quarterly estimates on strength in key unit - Reuters
- 15 days ago - Bio-Techne Declares Dividend - PRNewsWire
- 15 days ago - Bio-Techne Releases Second Quarter Fiscal 2026 Results - PRNewsWire
- 17 days ago - Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative - PRNewsWire
- 22 days ago - Madison Mid Cap Fund Q4 2025 Portfolio Activity - Seeking Alpha